Cure My Disease

Don't miss your cure!

 Log in / Sign up

Hip replacement device study pulled before it started

NCT ID NCT05560022

Disease control Sponsor: Societe dEtude, de Recherche et de Fabrication Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled This study
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study planned to test a new hip replacement device (the HYPE stem) in people with hip arthritis or other hip damage. The goal was to see how well the device works and if it is safe. However, the study was withdrawn before any participants were enrolled, so no results are available.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Started

Dec 2017

Expected to finish

Jan 2031

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

The implantation of the total hip prothesis will be performed in patients with a hip pathology in the first intention or during total prothesis revision

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Man or women * Degenerative or inflammatory hip pathology requiring a total hip replacement * Primary or secondary osteoarthritis * Advanced joint destruction resulting from rhumatoid arthritis or traumatic arthritis * Fracture or avascular necrosis * Sub-capital fracture and displaced transcervical as well as for bone defects stages I to IIb of PAPROSKY * Traumatic joint destruction * Following previous intervention, provided that the new device does not interfere with the material in place (osteosynthesis, joint reconstruction, arthrodesis, hemi-arthroplasty, total arthroplasty Exclusion Criteria: * People with diminished mental faculties * Known current pregnancy * Breast-feeding * Neurological disorders or other pathologies that may influence locomotion * Septic antecedent on hip to operate * Patient requiring a bone graft

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Avascular necrosis of the femoral head are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

avascular necrosis avascular necrosis of femoral head, primary, 1 femoral neck fracture hip fracture osteoarthritis, hip rheumatoid arthritis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Hip arthropathy

Contacts and locations

Locations

  • CHU de ROUEN

    Rouen, 76000, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.